Clincosm LogoSign in Get a demo

Metastatic Colorectal Cancer

Showing 26 - 50 of 500
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Colorectal Cancer, Chemo Effect, Peritoneal Metastases Trial in Lund, Malmö (Chemotherapy, Resection of the primary

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Lund, Skåne, Sweden
  • +1 more
Mar 6, 2023

Metastatic Colorectal Cancer Trial in Wuhan (SBRT, Fruquintinib, Cadonilimab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • SBRT, Fruquintinib, Cadonilimab
  • Wuhan, Hubei, China
    Cancer Center, Union Hospital, Tongji Medical College, Huazhong
Feb 18, 2023

Metastatic Colorectal Cancer Trial (ZN-c3, Encorafenib, Cetuximab)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • (no location specified)
Feb 15, 2023

Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)

Recruiting
  • Metastatic Colorectal Cancer
  • Oslo, Norway
    Oslo University Hospital
Feb 10, 2023

Colorectal Cancer, Metastatic Colorectal Cancer Trial in Almaty (D-isoascorbic Acid (D-VC) With Arsenic Trioxide (ATO),

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • D-isoascorbic Acid (D-VC) With Arsenic Trioxide (ATO)
  • FOLFOX/FOLFIRI regimen
  • Almaty, Kazakhstan
    Kazakh Institute of Oncology and Radiology
Feb 8, 2023

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Metastatic Colorectal Cancer Trial in Køge (Irreversible electroporation, Calcium electroporation, Pembrolizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Irreversible electroporation
  • +2 more
  • Køge, Denmark
    Zealand University Hospital
Jan 27, 2023

Metastatic Colorectal Cancer Trial in Duarte, St Leonards (Magrolimab, Bevacizumab, Irinotecan)

Recruiting
  • Metastatic Colorectal Cancer
  • Magrolimab
  • +4 more
  • Duarte, California
  • +19 more
Jan 27, 2023

Hepatocellular Carcinoma Non-resectable, Metastatic Colorectal Cancer, Liver Cancer Trial in Grafton (Eye90 Microspheres)

Recruiting
  • Hepatocellular Carcinoma Non-resectable
  • +2 more
  • Eye90 Microspheres
  • Grafton, New Zealand
    Auckland District Health Board
Jan 30, 2023

Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • mCRC
  • Tislelizumab & Fruquintinib
  • Guangzhou, Guangdong, China
  • +1 more
Jan 25, 2023

Metastatic Colorectal Cancer Trial in Worldwide (Encorafenib, Cetuximab, Pembrolizumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Phoenix, Arizona
  • +91 more
Jan 25, 2023

Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +38 more
Jan 25, 2023

Called RegoFlex EU, to Learn More About Use of Stivarga at

Completed
  • Metastatic Colorectal Cancer
  • Retrospective patient chart review
  • Whippany, New Jersey
    Many locations
Jan 24, 2023

Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute

Recruiting
  • Metastatic Colorectal Cancer
  • +4 more
  • Young TIL
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Metastatic Colorectal Cancer: A Clinical and Patient Perspective

Active, not recruiting
  • Metastatic Colorectal Cancer
  • observational disease study
  • Buenos Aires, Argentina
  • +17 more
Jan 24, 2023

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Metastatic Colorectal Cancer Trial in Los Angeles, Newark, Plantation (Selinexor, Pembrolizumab, Trifluridine)

Terminated
  • Metastatic Colorectal Cancer
  • Los Angeles, California
  • +2 more
Jan 24, 2023

First Line Treatment for BRAFV600E Mutant Metastatic Colorectal

Completed
  • BRAF V600E Mutation Positive
  • Metastatic Colorectal Cancer
  • Non Interventional study
  • St. Veit/Glan, Austria
  • +33 more
Jan 20, 2023

Metastatic Colorectal Cancer Trial in United States (mFOLFOX6, MVA-BN-CV301, FPV-CV301)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Duarte, California
  • +6 more
Jan 18, 2023

Metastatic Colorectal Cancer Trial in France (Folfirinox + regorrafenib)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Folfirinox + regorrafenib
  • Nice, Alpes-Maritimes, France
  • +3 more
Jan 16, 2023

Metastatic Colorectal Cancer Trial in India (Regorafenib (Stivarga, BAY73-4506))

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Regorafenib (Stivarga, BAY73-4506)
  • Hyderabad, Andhra Pradesh, India
  • +12 more
Jan 13, 2023

Metastatic Colorectal Cancer Trial in Worldwide (RO7122290, Cibisatamab, Obinutuzumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Toronto, Ontario, Canada
  • +15 more
Jan 13, 2023

Metastatic Colorectal Cancer Trial in Guangzhou (Fruquintinib alternating with Bevacizumab plus Capecitabine, Bevacizumab plus

Recruiting
  • Metastatic Colorectal Cancer
  • Fruquintinib alternating with Bevacizumab plus Capecitabine
  • Bevacizumab plus Capecitabine
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Jan 4, 2023

Metastatic Colorectal Cancer Trial in Pisa (Bevacizumab, Irinotecan, Oxaliplatin)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Pisa, Italia, Italy
    Francesca Vannini
Jan 4, 2023

Metastatic Colorectal Cancer Trial in Worldwide (Inavolisib, Bevacizumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Birmingham, Alabama
  • +36 more
Dec 29, 2022